COMP <GO>
ACCO vs CMPR // RETURN ON INVESTED CAPITAL (ROIC)
Acco Brands Corporation (NYSE) VS. Cimpress plc (Ireland) (NASDAQ) • 15-METRIC TALLY: ACCO 6
— CMPR 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: CMPR
LAST: $5.50 (+26.15%) • MKT CAP: $402.5M
roic
5.00%
LAST: $57.02 (-5.47%) • MKT CAP: $1.49B
roic
22.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACCO VS. CMPR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACCO | CMPR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.80% | 47.50% | -14.70 | CMPR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 5.00% | 22.70% | -17.70 | CMPR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.1x | 9.3x | +3.80 | CMPR | /valuation <GO> |
| Free Cash Flow Yield | 17.07% | 14.08% | +2.99 | ACCO | /fcf-yield <GO> |
| Operating Margin | 6.10% | 6.60% | -0.50 | CMPR | /operating-margins <GO> |
| Net Profit Margin | 2.70% | 0.40% | +2.30 | ACCO | /net-margins <GO> |
| Revenue Growth (YoY) | -8.50% | 3.40% | -11.90 | CMPR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 6.71% | 0.00% | +6.71 | ACCO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.70 | 2.34 | -1.64 | CMPR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | ACCO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.4 | 28.6 | +18.80 | ACCO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.0x | 92.3x | -83.30 | ACCO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $402.5M | $1.49B | -$1.08B | CMPR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACCO REV | CMPR REV | ACCO GROSS % | CMPR GROSS % | ACCO FCF | CMPR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.52B | $3.40B | 32.8% | 47.5% | $68.7M | $209.0M |
| FY 2024 | $1.67B | $3.29B | 33.3% | 48.5% | $148.2M | $295.8M |
| FY 2023 | $1.83B | $3.08B | — | — | $128.7M | $130.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACCO // BETA —
CMPR // BETA —